Biden's parting gift to Big Pharma will hammer GLP-1 patients - like meThe Biden administration's decision to end the shortage of tirzepatide risks making this essential medication unaffordable for many Americans.
The Crackdown on Compounded GLP-1 Meds Has BegunEli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.
Biden's parting gift to Big Pharma will hammer GLP-1 patients - like meThe Biden administration's decision to end the shortage of tirzepatide risks making this essential medication unaffordable for many Americans.
The Crackdown on Compounded GLP-1 Meds Has BegunEli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.
Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding DisputeThe ongoing demand for GLP-1s has resulted in a significant shortage and legal dispute regarding alternative compounding pharmacies.
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.Tirzepatide is no longer in shortage, but this may limit access to cheaper compounded versions in 2025.
Shady drugmaker used code words to sell knockoff weight-loss drug: lawsuitPivotal Peptides is allegedly operating in a way that poses significant risks to patient safety, utilizing coded language for product orders.
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. SaysThe FDA has resolved the tirzepatide shortage, improving access to brand-name drugs but disrupting the compounded medication market.
Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding DisputeThe ongoing demand for GLP-1s has resulted in a significant shortage and legal dispute regarding alternative compounding pharmacies.
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.Tirzepatide is no longer in shortage, but this may limit access to cheaper compounded versions in 2025.
Shady drugmaker used code words to sell knockoff weight-loss drug: lawsuitPivotal Peptides is allegedly operating in a way that poses significant risks to patient safety, utilizing coded language for product orders.
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. SaysThe FDA has resolved the tirzepatide shortage, improving access to brand-name drugs but disrupting the compounded medication market.
Drug makers can't make knockoff weight-loss drugs anymore-and they're madCompounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.
Evidence Is Growing That Ozempic Can Cause BlindnessDrugs like Ozempic and Mounjaro are linked to severe eye conditions, particularly NAION, causing increasing concern among healthcare providers.
Drug makers can't make knockoff weight-loss drugs anymore-and they're madCompounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.
Evidence Is Growing That Ozempic Can Cause BlindnessDrugs like Ozempic and Mounjaro are linked to severe eye conditions, particularly NAION, causing increasing concern among healthcare providers.
A New Wave of Anti-Obesity Drugs Is on the WayTirzepatide's dual receptor activation may contribute to its efficacy in weight loss, while GIP's role is not fully understood yet.
Mounjaro Appears to Be Extremely Effective at Preventing DiabetesTirzepatide may reduce diabetes risk by 94% and help in weight loss for high-risk individuals.
Eli Lilly Offering Way Cheaper Zepbound, If You're Willing to Buy Your Own SyringesZepbound's new self-dosing option provides significant cost savings for patients willing to administer their own injections.
Weight loss drug could ease sleep apnoea in people with obesity, study saysTirzepatide, a drug for diabetes and weight loss, could potentially be the first pharmaceutical treatment for obstructive sleep apnoea (OSA) in people with obesity.
How does weight loss drug Mounjaro work and why is it in such high demand?Mounjaro, a leading weight loss drug, will be rolled out on the NHS prioritizing patients with significant health needs over 12 years.
The First Sleep Apnea Drug Is HereZepbound gains FDA approval for treating obstructive sleep apnea, marking a breakthrough in weight-loss medication benefits.
A New Wave of Anti-Obesity Drugs Is on the WayTirzepatide's dual receptor activation may contribute to its efficacy in weight loss, while GIP's role is not fully understood yet.
Mounjaro Appears to Be Extremely Effective at Preventing DiabetesTirzepatide may reduce diabetes risk by 94% and help in weight loss for high-risk individuals.
Eli Lilly Offering Way Cheaper Zepbound, If You're Willing to Buy Your Own SyringesZepbound's new self-dosing option provides significant cost savings for patients willing to administer their own injections.
Weight loss drug could ease sleep apnoea in people with obesity, study saysTirzepatide, a drug for diabetes and weight loss, could potentially be the first pharmaceutical treatment for obstructive sleep apnoea (OSA) in people with obesity.
How does weight loss drug Mounjaro work and why is it in such high demand?Mounjaro, a leading weight loss drug, will be rolled out on the NHS prioritizing patients with significant health needs over 12 years.
The First Sleep Apnea Drug Is HereZepbound gains FDA approval for treating obstructive sleep apnea, marking a breakthrough in weight-loss medication benefits.
Mounjaro, the 'King Kong' of weight loss jabs, will be available in Ireland early next yearMounjaro is an effective treatment option for obesity and type 2 diabetes, approved for use with diet and physical activity.
Which Weight Loss Drug Should You Choose (if You Get to Choose)?People with obesity now have a choice between semaglutide and tirzepatide for weight loss, but deciding which to take is complex.
Mounjaro, the 'King Kong' of weight loss jabs, will be available in Ireland early next yearMounjaro is an effective treatment option for obesity and type 2 diabetes, approved for use with diet and physical activity.
Which Weight Loss Drug Should You Choose (if You Get to Choose)?People with obesity now have a choice between semaglutide and tirzepatide for weight loss, but deciding which to take is complex.
Weight-loss drug reduces risk of early death for patients with heart failure, trial findsTirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.
Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year TrialLilly's weight loss injectables Zepbound and Mounjaro significantly reduce diabetes risk, showing lasting effects even after treatment ends.
Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offsEli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.
Eli Lilly Blasts Use of Mounjaro and Zepbound for "Cosmetic Weight Loss"Pharmaceutical company Eli Lilly is warning against off-label use of its weight loss medications.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Eli Lilly's stock has risen 464.44% since 2020, indicating strong growth potential and key clinical advancements shaping its future.With a focus on research in oncology and diabetes prevention, Eli Lilly is well-positioned for sustained growth in the coming years.
Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year TrialLilly's weight loss injectables Zepbound and Mounjaro significantly reduce diabetes risk, showing lasting effects even after treatment ends.
Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offsEli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.
Eli Lilly Blasts Use of Mounjaro and Zepbound for "Cosmetic Weight Loss"Pharmaceutical company Eli Lilly is warning against off-label use of its weight loss medications.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Eli Lilly's stock has risen 464.44% since 2020, indicating strong growth potential and key clinical advancements shaping its future.With a focus on research in oncology and diabetes prevention, Eli Lilly is well-positioned for sustained growth in the coming years.
The Benefits of Ozempic Are MultiplyingSemaglutide and tirzepatide mimic GLP-1 to control blood sugar levels and induce feelings of fullness, potentially offering benefits for kidney protection and reducing inflammation in conditions like dementia.